Video Experimental Relacionado
Updated: Mar 6, 2026
10:41
An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
10.9K
El epigenoma del cáncer: conceptos, desafíos y oportunidades terapéuticas
1Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia; and Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Science (New York, N.Y.)
|March 18, 2017
Resumen
Las alteraciones epigenéticas impulsan el desarrollo y la evolución del cáncer. Esta revisión cubre nuevas terapias epigenéticas dirigidas al cáncer, explorando mecanismos de sensibilidad, resistencia y futuras estrategias de combinación.
Área de la Ciencia:
- En el campo de la oncología
- La epigenética
- Biología del cáncer
Sus antecedentes:
- Las modificaciones epigenéticas juegan un papel crucial en la biología del cáncer.
- La plasticidad del epigenoma permite la intervención terapéutica.
- Los avances recientes se centran en las terapias epigenéticas específicas para el cáncer.
Objetivo del estudio:
- Proporcionar una visión global de los desarrollos recientes en las terapias epigenéticas para el cáncer.
- Aclarar el papel de los reguladores epigenéticos en el inicio, mantenimiento y evolución del cáncer.
- Discutir los mecanismos de sensibilidad y resistencia a los agentes epigenéticos y explorar futuras terapias combinadas.
Principales métodos:
- Revisión de la literatura actual sobre los reguladores epigenéticos en el cáncer.
- Análisis de nuevas terapias epigenéticas desarrolladas.
- Examen de los mecanismos celulares y moleculares que rigen la respuesta al tratamiento.
- Exploración de la lógica de las terapias combinadas de fármacos epigenéticos.
Principales resultados:
- Los reguladores epigenéticos son factores clave en el inicio, mantenimiento y evolución del cáncer.
- Están surgiendo nuevas terapias epigenéticas con potencial para el tratamiento del cáncer.
- La comprensión de los mecanismos de sensibilidad y resistencia es crucial para el éxito terapéutico.
- Las terapias combinadas que involucran medicamentos epigenéticos son prometedoras para una mayor eficacia.
Conclusiones:
- Las terapias epigenéticas dirigidas representan un avance significativo en el tratamiento del cáncer.
- Se necesitan más investigaciones sobre los mecanismos de resistencia y las estrategias de combinación.
- Los medicamentos epigenéticos tienen potencial para mejorar los resultados de los pacientes en oncología.
Videos de Conceptos Relacionados
01:37Epigenetic Regulation
4.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.0K
01:46Epigenetic Regulation
34.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:18Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K